Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001348362-24-000006

Chief Executive Officer bought 50,000 shares at an average $2.37 ($118,392)

From the SEC's structured data for this filing

Trades in this filing

CHRISTOPHER RICHARD · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-02 Purchase : show line 1 in the form +22,828 $2.24 $51,217 22,828 D
2024-12-03 Purchase : show line 2 in the form +27,172 $2.47 $67,175 50,000 D
Open-market purchases · 50,000 sh · avg $2.37 · $118,392
Loading xslF345X05/primary_doc.xml…